Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
33 studies found for:    " February 18, 2013":" March 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults
Conditions: Influenza;   HIV;   Tuberculosis
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
22 Recruiting Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders
Condition: HIV
Interventions: Drug: Triptolide;   Drug: cART;   Drug: placebo
23 Completed Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB
Condition: HIV/TB Co-infection
Interventions: Drug: Nevirapine;   Drug: Efavirenz
24 Recruiting The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers
Conditions: HIV;   Smoking Cessation
Interventions: Drug: Nicotine Replacement Therapy (NRT);   Drug: Varenicline;   Behavioral: HIV Tailored Quit Smoking Counseling
25 Completed Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers
Condition: HIV
Intervention: Drug: Eviplera®
26 Recruiting THISTLE - The HIV-HCV Silibinin Trial
Conditions: HIV;   Hepatitis C
Intervention: Drug: Intravenous Silibinin (iSIL)
27 Recruiting Enhancing Quality Interventions Promoting Healthy Sexuality
Conditions: Pregnancy in Adolescence;   HIV
Interventions: Behavioral: Making Proud Choices;   Behavioral: Making Proud Choices AND Getting To Outcomes
28 Recruiting Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
Condition: HIV+
Intervention:
29 Active, not recruiting In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% gel;   Drug: Vaginal product
30 Completed Biomarkers of Protocol Compliance and Product Adherence
Condition: HIV Prevention
Intervention: Other: HEC placebo gel applicators
31 Recruiting Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
Condition: HIV Prevention
Interventions: Drug: TFV 1% gel;   Drug: Estradiol vaginal cream
32 Recruiting Study to Evaluate a HIV Drug for the Treatment of HIV Infection
Condition: HIV-1 Infection
Interventions: Drug: BMS-955176;   Drug: Placebo matching with BMS-955176;   Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir;   Drug: Emtricitabine
33 Active, not recruiting Feasibility of Non-pharmacological Insomnia Therapy in People Living With HIV
Conditions: Insomnia;   Sleep Efficiency
Interventions: Behavioral: Cognitive Behavioral Therapy;   Behavioral: Behavioral Modification

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-33) Next Page   
Indicates status has not been verified in more than two years